Note 26 - Quarterly Results of Operations (Unaudited)

12 Months Ended

Dec. 31, 2014

Quarterly Financial Information Disclosure [Abstract]

Quarterly Financial Information [Text Block]

Note 26 — Quarterly Results of Operations (Unaudited)

	Three Months Ended
	March 31,			June 30,			September 30, (a)			December 31, (b)
	(in thousands except per share data)
2014
Total net revenue	$	20,976		$	24,255		$	20,350		$	18,316
Operating income (loss)		2,123			4,363			(40,084	)		(24,077	)
Other expense		(3,743	)		(4,787	)		(2,580	)		(8,147	)
Net loss	$	(3,570	)	$	(2,549	)	$	(45,292	)	$	(56,495	)
Basic net loss per share	$	(0.03	)	$	(0.02	)	$	(0.39	)	$	(0.49	)
Diluted net loss per share	$	(0.03	)	$	(0.02	)	$	(0.39	)	$	(0.49	)
Basic weighted average common shares outstanding		116,042			116,342			116,399			116,453
Diluted weighted average common shares outstanding		116,042			116,342			116,399			116,453

	Three Months Ended
	March 31,			June 30,			September 30,			December 31,
	(in thousands except per share data)
2013
Total net revenue	$	13,312		$	12,815		$	12,529		$	12,073
Operating loss		(7,241	)		(12,664	)		(10,853	)		(5,656	)
Other expense		(5,213	)		(7,353	)		(10,239	)		(4,267	)
Net loss	$	(12,784	)	$	(19,640	)	$	(15,321	)	$	(9,966	)
Basic net loss per share	$	(0.11	)	$	(0.17	)	$	(0.13	)	$	(0.09	)
Diluted net loss per share	$	(0.11	)	$	(0.17	)	$	(0.13	)	$	(0.09	)
Basic weighted average common shares outstanding		115,788			115,935			116,009			116,035
Diluted weighted average common shares outstanding		115,788			115,935			116,009			116,035

(a) Includes asset impairments of $41.0 million and an increase to the deferred income tax valuation allowance of $9.9 million.

(b) Includes asset impairments of $17.0 million and an increase to the deferred income tax valuation allowance of $32.3 million.